Work for Y-mAbs Therapeutics, Inc.?

Claim Your Profile

Y-mAbs Therapeutics, Inc. Logo Image

Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc. Banner Image

About Y-mAbs Therapeutics, Inc.

51-200 Employees
Based in New York City, New York

Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The Company has a broad and advanced product pipeline, including two pivotal-stage product candidates naxitamab and omburtamab—which target tumors that express GD2 and B7-H3, respectively.

Ticker:
YMAB
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol